- 欧林生物 (688319)- 非流动负债

按负债周期分类:一年以上到期的非流动负债分析

归母股东权益

9.1亿    ,2.1,1.9,3.4,3.8,8.4,8.8,9.2,9.1
了解明细
少数股东权益

0.1亿    ,0,0,0,0,0,0.1,0.1,0.1
了解明细
负债合计

7.9亿    ,0.6,0.9,1.5,2.6,3.7,5.9,6.8,7.9
了解明细
资产合计

17.1亿    ,2.7,2.8,4.9,6.4,12.1,14.8,16.1,17.1
了解明细



流动负债

4.8亿    ,0.5,0.9,1.4,2.4,3.4,5.3,4.8,4.8
28.1%
了解明细
非流动负债

3.0亿    ,0.0,0.0,0.1,0.2,0.3,0.6,2.1,3.0
17.6%
了解明细



长期借款

2.7亿    ,0,0,0,0,0,0.3,1.8,2.7
了解明细
应付债券

0亿    ,0,0,0,0,0,0,0,0
了解明细
长期应付款

0亿    ,0.0,0.0,0.1,0.0,0,0,0,0
了解明细
专项应付款

0亿    ,0,0,0,0,0,0,0,0
了解明细
预计负债

0.0亿    ,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
了解明细
递延所得税负债

0.0亿    ,0,0,0,0,0.0,0.0,0.0,0.0
了解明细
递延收益-非流动负债

0.2亿    ,0.0,0.0,0.0,0.2,0.2,0.2,0.2,0.2
了解明细
其他非流动负债

0亿    ,0,0,0,0,0,0,0,0
了解明细